The glutathione S-transferase Mu 1 (GSTM1) antibody is a key tool for studying the GSTM1 enzyme, a member of the glutathione S-transferase (GST) family involved in detoxifying electrophilic compounds by conjugating glutathione. GSTM1 plays a critical role in cellular defense against oxidative stress, carcinogens, and environmental toxins. Notably, the GSTM1 gene exhibits a common polymorphism—a homozygous deletion (null genotype) in approximately 50% of certain populations—which is linked to altered susceptibility to cancers, neurodegenerative diseases, and drug metabolism disorders.
GSTM1 antibodies are designed to detect and quantify the presence of the GSTM1 protein in tissues or biological samples. They are widely used in techniques like Western blotting, immunohistochemistry, and ELISA to investigate GSTM1 expression patterns in disease models, pharmacogenomics, and toxicology studies. These antibodies help identify individuals with functional GSTM1 variants versus null genotypes, aiding research on personalized medicine and biomarker discovery.
Most GSTM1 antibodies are raised against specific epitopes of the human protein, though cross-reactivity with orthologs in model organisms (e.g., mice, rats) is often validated. Their applications extend to exploring GSTM1's role in chemoresistance, oxidative stress pathways, and interactions with signaling molecules like JNK. As GSTM1's dysregulation is implicated in cancer progression and drug efficacy, its antibodies remain vital for mechanistic and translational research.